These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. A phase II randomized placebo-controlled double-blind study of salvage radiation therapy plus placebo versus SRT plus enzalutamide with high-risk PSA-recurrent prostate cancer after radical prostatectomy (SALV-ENZA). Kapoor R; Deek MP; McIntyre R; Raman N; Kummerlowe M; Chen I; Gaver M; Wang H; Denmeade S; Lotan T; Paller C; Markowski M; Carducci M; Eisenberger M; Beer TM; Song DY; DeWeese TL; Hearn JW; Greco S; DeVille C; Desai NB; Heath EI; Liauw S; Spratt DE; Hung AY; Antonarakis ES; Tran PT BMC Cancer; 2019 Jun; 19(1):572. PubMed ID: 31196032 [TBL] [Abstract][Full Text] [Related]
9. The impact of salvage radiotherapy initiation at PSA ≤ 0.5 ng/ml on metastasis-free survival in patients with relapsed prostate cancer following prostatectomy. Lee EE; Singh T; Hu C; Han M; Deville CJ; Halthore A; Greco S; Tran P; DeWeese T; Song DY Prostate; 2023 Feb; 83(2):190-197. PubMed ID: 36316967 [TBL] [Abstract][Full Text] [Related]
10. Outcomes of salvage radiotherapy for recurrent prostate cancer after radical prostatectomy. Lee EK; Mui WH; Chan AW; Tung Y; Wong FC Hong Kong Med J; 2018 Jun; 24(3):218-225. PubMed ID: 29807949 [TBL] [Abstract][Full Text] [Related]
11. Optimizing the Timing of Salvage Postprostatectomy Radiotherapy and the Use of Concurrent Hormonal Therapy for Prostate Cancer. Kishan AU; Tendulkar RD; Tran PT; Parker CC; Nguyen PL; Stephenson AJ; Carrie C Eur Urol Oncol; 2018 May; 1(1):3-18. PubMed ID: 31100226 [TBL] [Abstract][Full Text] [Related]
12. Use of androgen deprivation and salvage radiation therapy for patients with prostate cancer and biochemical recurrence after prostatectomy. Ghadjar P; Aebersold DM; Albrecht C; Böhmer D; Flentje M; Ganswindt U; Höcht S; Hölscher T; Sedlmayer F; Wenz F; Zips D; Wiegel T; Strahlenther Onkol; 2018 Jul; 194(7):619-626. PubMed ID: 29383406 [TBL] [Abstract][Full Text] [Related]
13. Anti-Androgen Therapy Overcomes the Time Delay in Initiation of Salvage Radiation Therapy and Rescues the Oncological Outcomes in Men with Recurrent Prostate Cancer After Radical Prostatectomy: A Post Hoc Analysis of the RTOG-9601 Trial Data. Sood A; Keeley J; Palma-Zamora I; Chien M; Corsi N; Jeong W; Rogers CG; Trinh QD; Peabody JO; Menon M; Abdollah F Ann Surg Oncol; 2022 Oct; 29(11):7206-7215. PubMed ID: 35608801 [TBL] [Abstract][Full Text] [Related]
14. High-dose salvage intensity-modulated radiotherapy with or without androgen deprivation after radical prostatectomy for rising or persisting prostate-specific antigen: 5-year results. Ost P; Lumen N; Goessaert AS; Fonteyne V; De Troyer B; Jacobs F; De Meerleer G Eur Urol; 2011 Oct; 60(4):842-9. PubMed ID: 21514039 [TBL] [Abstract][Full Text] [Related]
16. Salvage radiotherapy with or without short-term hormone therapy for rising prostate-specific antigen concentration after radical prostatectomy (GETUG-AFU 16): a randomised, multicentre, open-label phase 3 trial. Carrie C; Hasbini A; de Laroche G; Richaud P; Guerif S; Latorzeff I; Supiot S; Bosset M; Lagrange JL; Beckendorf V; Lesaunier F; Dubray B; Wagner JP; N'Guyen TD; Suchaud JP; Créhange G; Barbier N; Habibian M; Ferlay C; Fourneret P; Ruffion A; Dussart S Lancet Oncol; 2016 Jun; 17(6):747-756. PubMed ID: 27160475 [TBL] [Abstract][Full Text] [Related]
17. Clinical Outcome of Salvage Radiotherapy for Locoregional Clinical Recurrence After Radical Prostatectomy. Lee SU; Cho KH; Kim JH; Kim YS; Nam TK; Kim JS; Cho J; Choi SH; Shim SJ; Kim JH; Chang AR Technol Cancer Res Treat; 2021; 20():15330338211041212. PubMed ID: 34806469 [No Abstract] [Full Text] [Related]
18. The Dedicated Imaging Post-Prostatectomy for Enhanced Radiotherapy outcomes (DIPPER) trial protocol: a multicentre, randomised trial of salvage radiotherapy versus surveillance for low-risk biochemical recurrence after radical prostatectomy. Roberts MJ; Conduit C; Davis ID; Effeney RM; Williams S; Martin JM; Hofman MS; Hruby G; Eapen R; Gianacas C; Papa N; Lourenço RA; Dhillon HM; Allen R; Fontela A; Kaur B; Emmett L; BJU Int; 2024 Feb; 133 Suppl 3():39-47. PubMed ID: 37604702 [TBL] [Abstract][Full Text] [Related]
19. Salvage Radiotherapy for Recurrent Prostate Cancer: Can the Prognostic Grade Group System Inform Treatment Timing? Tay KJ; Polascik TJ; Howard LE; Salama JK; Schulman AA; Chen Z; Amling CL; Aronson WJ; Cooperberg MR; Kane CJ; Terris MK; Freedland SJ Clin Genitourin Cancer; 2019 Oct; 17(5):e930-e938. PubMed ID: 31257075 [TBL] [Abstract][Full Text] [Related]